Skip to main content
Presentation
Mortality rates of patients treated with drotrecogin alfa for severe sepsis based on PROWESS eligibility
Pharmaceutical Sciences
  • E. Dodds Ashley
  • Richard H. Drew
  • M. Goodwin
  • D. B. May
  • A. Scates
Document Type
Abstract
Date of Publication
1-1-2007
Event
American College of Clinical Pharmacy Annual Meeting
Citation Information
E. Dodds Ashley, Richard H. Drew, M. Goodwin, D. B. May, et al.. "Mortality rates of patients treated with drotrecogin alfa for severe sepsis based on PROWESS eligibility" (2007)
Available at: http://works.bepress.com/dbyron-may/63/